Report : North America Arterial Blood Gas Kits Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (1mL [Syringe Volume], 3mL [Syringe Volume]), and Others); End User (Hospitals, Clinics, and Others)
3 mL (Syringe Volume) Segment has the Largest Share of Product in the North America Arterial Blood Gas Kits Market during 2021–2028
According to a new market research study on “North America Arterial Blood Gas Kits Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, and End User” is expected to reach US$ 302.7 million by 2028 from US$ 176.3 million in 2021. The market is estimated to grow at a CAGR of 8.0% from 2021 to 2028. The report provides trends prevailing in the North America Arterial blood gas kits market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing prevalence of respiratory diseases and growing prevalence of metabolic and kidney diseases are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the challenges such as risks, complications, and sampling errors associated with arterial blood sampling.
COVID-19 pandemic has served vital growth opportunities for the arterial blood gas kits market. The market has experienced exponential growth during the pandemic due to tremendous demand for oxygen level testing through arterial blood gas kits. North America is the leading market that has significantly contributed to the growth of the market. There have been various factors, including increased incidences of COVID-19 positive patients, growth in arterial blood gas kits technologies, increasing production of kits, and many other factors. The cases majorly led to the demand for arterial blood gas kits testing in the countries like the US, Canada, and Mexico. Similarly, other countries have experienced a rise in the incidences of COVID-19 positive, which have demanded arterial blood gas kits testing. The other major factor that has driven the market’s growth is developments for arterial blood gas kits. Besides various product approvals are gaining traction in the market. For instance, in July 2017, Teleflex Incorporated has received U.S. Food and Drug Administration (FDA) approval for Arrow Seldinger Arterial Catheterization Device which can be used for arterial blood gas estimation. Besides, the FDA has increased its efforts to support the health of people and has imposed several guidelines and for hospitals and medical device companies. Various companies also enhanced their research and development activities for diagnostics tests and therapeutic devices. Thus, increased production by the companies has resulted in profits, and the outbreak of COVID-19 has shown a positive impact on market growth.
The market for arterial blood gas kits market is segmented into product, and end user. Based on product, the arterial blood gas kits market is segmented into 1 mL, 3 mL, and other syringe volumes. In 2021, the 3 ml segment accounted for the largest share of the market and accounted for the highest CAGR. Innovative products offered by the market players operating in this space is likely to favour market growth of this segment. For instance, Pro-Vent Plus 3 mL Arterial Blood Sampling syringes by Smith Medical uses lithium heparin with a concentration of 23.5 I.U. per mL. The specially formulated dry lithium heparin offers the necessary anticoagulation along with minimal interference for more accurate results.
Becton Dickinson and Company, Radiometer Medical ApS, Smiths Medical, Vyaire Medical, Opti Medical Systems, Inc., Westmed Medical, Siemens Healthineers AG, ITL Biomedical, i-SENS, Inc., and Teleflex Incorporated are among the leading companies in the North America arterial blood gas kits market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in April 2020, Teleflex Incorporated and Premier, a leading healthcare improvement company has signed partnership agreement to improve market utilization of Teleflex's Arrow Brand vascular access products.
The market for arterial blood gas kits market is segmented into product, and end user. Based on product, the arterial blood gas kits market is segmented into 1 mL, 3 mL, and other syringe volumes. Based on end user, the arterial blood gas kits market is segmented into hospitals, clinics, and others. Geographically, the arterial blood gas kits market is segmented into North America (US, Canada, Mexico).
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org